Xavier Le Goff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xavier Le Goff has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
Anne Couturier
IGDR (Institut de ge ´ne ´tique et de ´veloppement de Rennes)-UMR 6290 Univ Rennes CNRS France
10 shared publicationsFranck Chesnel
IGDR (Institut de ge ´ne ´tique et de ´veloppement de Rennes)-UMR 6290 Univ Rennes CNRS France
7 shared publicationsCathy Le Goff
CNRS, UMR 6290 IGDR, Université Rennes 1, BIOSIT, Rennes, France
6 shared publications- Yannick Arlot-Bonnemains
Mixed Research Unit 6290, National Center for Scientific Research (CNRS), Institute of Genetics and Development of Rennes, University of Rennes 1, 35043 Rennes, France
5 shared publications Angela Cadou
CNRS UMR6290 Institut de Génétique et Développement de Rennes, France
3 shared publicationsFlorence Jouan
CNRS, UMR 6290 IGDR, Université Rennes 1, BIOSIT, Rennes, France
3 shared publications
Latest Publications
- Open Access
- 2 November 2020
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 16 (11) , e1009183
The prefoldin complex stabilizes the von Hippel-Lindau protein against aggregation and degradation
Loss of von Hippel-Lindau protein pVHL function promotes VHL diseases, including sporadic and inherited clear cell Renal Cell Carcinoma (ccRCC). Mechanisms controlling pVHL function and regulation, including folding and stability, remain elusive. Here, we have identified the conserved cochaperone prefoldin complex in a screen for pVHL interactors. The prefoldin complex delivers non-native proteins to the chaperonin T-complex-protein-1-ring (TRiC) or Cytosolic Chaperonin containing TCP-1 (CCT) to assist folding of newly synthesized polypeptides. The pVHL-prefoldin interaction was confirmed in human cells and prefoldin knock-down reduced pVHL expression levels. Furthermore, when pVHL was expressed inSchizosaccharomyces pombe, all prefoldin mutants promoted its aggregation. We mapped the interaction of prefoldin with pVHL at the exon2-exon3 junction encoded region. Low levels of the PFDN3 prefoldin subunit were associated with poor survival in ccRCC patients harboring VHL mutations. Our results link the prefoldin complex with pVHL folding and this may impact VHL diseases progression.
- 2 November 2020
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 16 (11) , e1009183
Open AccessThe prefoldin complex stabilizes the von Hippel-Lindau protein against aggregation and degradation
Loss of von Hippel-Lindau protein pVHL function promotes VHL diseases, including sporadic and inherited clear cell Renal Cell Carcinoma (ccRCC). Mechanisms controlling pVHL function and regulation, including folding and stability, remain elusive. Here, we have identified the conserved cochaperone prefoldin complex in a screen for pVHL interactors. The prefoldin complex delivers non-native proteins to the chaperonin T-complex-protein-1-ring (TRiC) or Cytosolic Chaperonin containing TCP-1 (CCT) to assist folding of newly synthesized polypeptides. The pVHL-prefoldin interaction was confirmed in human cells and prefoldin knock-down reduced pVHL expression levels. Furthermore, when pVHL was expressed inSchizosaccharomyces pombe, all prefoldin mutants promoted its aggregation. We mapped the interaction of prefoldin with pVHL at the exon2-exon3 junction encoded region. Low levels of the PFDN3 prefoldin subunit were associated with poor survival in ccRCC patients harboring VHL mutations. Our results link the prefoldin complex with pVHL folding and this may impact VHL diseases progression.
- 29 May 2020
- Published by Springer Nature in The European Physical Journal E
- Vol. 43 (5) , 1-8
Ends and middle: Global force balance and septum location in fission yeast
The fission yeast cell is shaped as a very regular cylinder ending by hemi-spheres at both cell ends. Its conserved phenotypes are often used as read-outs for classifying interacting genes and protein networks. Using Pascal and Young-Laplace laws, we proposed a framework where scaling arguments predicted shapes. Here we probed quantitatively one of these relations which predicts that the division site would be located closer to the cell end with the larger radius of curvature. By combining genetics and quantitative imaging, we tested experimentally whether altered shapes of cell end correlate with a displaced division site, leading to asymmetric cell division. Our results show that the division site position depends on the radii of curvatures of both ends. This new geometrical mechanism for the proper division plane positioning could be essential to achieve even partitioning of cellular material at each cell division. Graphical abstract
- 29 May 2020
- Published by Springer Nature in The European Physical Journal E
- Vol. 43 (5) , 1-8
Ends and middle: Global force balance and septum location in fission yeast
The fission yeast cell is shaped as a very regular cylinder ending by hemi-spheres at both cell ends. Its conserved phenotypes are often used as read-outs for classifying interacting genes and protein networks. Using Pascal and Young-Laplace laws, we proposed a framework where scaling arguments predicted shapes. Here we probed quantitatively one of these relations which predicts that the division site would be located closer to the cell end with the larger radius of curvature. By combining genetics and quantitative imaging, we tested experimentally whether altered shapes of cell end correlate with a displaced division site, leading to asymmetric cell division. Our results show that the division site position depends on the radii of curvatures of both ends. This new geometrical mechanism for the proper division plane positioning could be essential to achieve even partitioning of cellular material at each cell division. Graphical abstract
- 4 November 2019
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 35 (47) , 15121-15130
Liposomes Containing Nickel–Bis(dithiolene) Complexes for Photothermal Theranostics
New thermosensitive liposomes with a phase transition at 42°C, containing nickel-bis(dithiolene) complexes as efficient and stable photothermal agents, have been formulated and characterized. These liposomes are highly stable and keep their contents at 37°C for more than 30 days. On the contrary, the mild hyperthermia generated by the nickel-bis(dithiolene) complex under 940 nm NIR irradiation allows for the fine controlled release of the liposome contents, making such liposomes highly suitable for on-demand drug delivery in human body under NIR laser irradiation. These liposomes can also be directly used, as shown here, as nano-agents for photothermal therapy. In fact, strong cell death can be generated under laser irradiation in presence of these photothermally active nanocargos containing less than 10%w/w of metal complex. We also demonstrate, for the first time, that nickel-bis(dithiolene) complexes are good photoacoustic agents, generating easily detectable ultrasonic signals directly proportional to the concentration of complexes and the used laser power.
- 4 November 2019
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 35 (47) , 15121-15130
Liposomes Containing Nickel–Bis(dithiolene) Complexes for Photothermal Theranostics
New thermosensitive liposomes with a phase transition at 42°C, containing nickel-bis(dithiolene) complexes as efficient and stable photothermal agents, have been formulated and characterized. These liposomes are highly stable and keep their contents at 37°C for more than 30 days. On the contrary, the mild hyperthermia generated by the nickel-bis(dithiolene) complex under 940 nm NIR irradiation allows for the fine controlled release of the liposome contents, making such liposomes highly suitable for on-demand drug delivery in human body under NIR laser irradiation. These liposomes can also be directly used, as shown here, as nano-agents for photothermal therapy. In fact, strong cell death can be generated under laser irradiation in presence of these photothermally active nanocargos containing less than 10%w/w of metal complex. We also demonstrate, for the first time, that nickel-bis(dithiolene) complexes are good photoacoustic agents, generating easily detectable ultrasonic signals directly proportional to the concentration of complexes and the used laser power.
- Open Access
Ends and middle: global force balance determines septum location in fission yeast
The fission yeast cell is shaped as a very regular cylinder ending by hemi-spheres at both cell ends. Its conserved phenotypes are often used as read-outs for classifying interacting genes and protein networks. Using Pascal and Young-Laplace laws, we proposed a framework where scaling arguments predicted shapes. Here we probed quantitatively one of these relations which predicts that the division site would be located closer to the cell end with the larger radius of curvature. By combining genetics and quantitative imaging, we tested experimentally whether altered shapes of cell end correlate with a displaced division site, leading to asymmetric cell division. Our results show that the division site position depends on the radii of curvatures of both ends. This new geometrical mechanism for the proper division plane positioning could be essential to achieve even partitioning of cellular material at each cell division.
Open AccessEnds and middle: global force balance determines septum location in fission yeast
The fission yeast cell is shaped as a very regular cylinder ending by hemi-spheres at both cell ends. Its conserved phenotypes are often used as read-outs for classifying interacting genes and protein networks. Using Pascal and Young-Laplace laws, we proposed a framework where scaling arguments predicted shapes. Here we probed quantitatively one of these relations which predicts that the division site would be located closer to the cell end with the larger radius of curvature. By combining genetics and quantitative imaging, we tested experimentally whether altered shapes of cell end correlate with a displaced division site, leading to asymmetric cell division. Our results show that the division site position depends on the radii of curvatures of both ends. This new geometrical mechanism for the proper division plane positioning could be essential to achieve even partitioning of cellular material at each cell division.
- 13 August 2018
- Published by Wiley in Particle & Particle Systems Characterization
- Vol. 35 (10)
Insights into the Photothermal Hydrogen Production from Glycerol Aqueous Solutions over Noble Metal‐Free Ti@TiO2 Core–Shell Nanoparticles
Photocatalytic production of hydrogen from renewable sources with platinum group metal‐free catalysts is of great importance for environmentally friendly energetics. Herein, Ti@TiO2 core–shell nanoparticles prepared by sonohydrothermal treatment of titanium metal nanoparticles are examined for hydrogen generation from aqueous glycerol solutions under vis/NIR light irradiation. It is shown that photocatalytic reforming of glycerol in the presence of Ti@TiO2 exhibits strong photothermal effect allowing more efficient use of solar energy. Apparent activation energy equal to E act = 27 ± 2 kJ mol−1 indicates that the thermal effect is related to the diffusion of reaction intermediates at catalyst surface rather than to the activation of chemical bonds. The photoexcitation mechanism of Ti@TiO2 particles involves interband transitions in nonplasmonic Ti metal core followed by nonradiative Landau damping. Effective electron–hole separation between Ti core and nanocrystalline TiO2 anatase shell in Ti@TiO2 nanoparticles is confirmed by photoluminescence spectroscopy. In studied system, photothermal hydrogen production is not accompanied by CO2 emission indicating that glycerol is oxidized to glyceric acid without further decarboxylation.
- 13 August 2018
- Published by Wiley in Particle & Particle Systems Characterization
- Vol. 35 (10)
Insights into the Photothermal Hydrogen Production from Glycerol Aqueous Solutions over Noble Metal‐Free Ti@TiO2 Core–Shell Nanoparticles
Photocatalytic production of hydrogen from renewable sources with platinum group metal‐free catalysts is of great importance for environmentally friendly energetics. Herein, Ti@TiO2 core–shell nanoparticles prepared by sonohydrothermal treatment of titanium metal nanoparticles are examined for hydrogen generation from aqueous glycerol solutions under vis/NIR light irradiation. It is shown that photocatalytic reforming of glycerol in the presence of Ti@TiO2 exhibits strong photothermal effect allowing more efficient use of solar energy. Apparent activation energy equal to E act = 27 ± 2 kJ mol−1 indicates that the thermal effect is related to the diffusion of reaction intermediates at catalyst surface rather than to the activation of chemical bonds. The photoexcitation mechanism of Ti@TiO2 particles involves interband transitions in nonplasmonic Ti metal core followed by nonradiative Landau damping. Effective electron–hole separation between Ti core and nanocrystalline TiO2 anatase shell in Ti@TiO2 nanoparticles is confirmed by photoluminescence spectroscopy. In studied system, photothermal hydrogen production is not accompanied by CO2 emission indicating that glycerol is oxidized to glyceric acid without further decarboxylation.
- Open Access
- 6 June 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (44) , 75989-76002
The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes includingTGFB1andMMP13
The pVHL 172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13 The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13
- 6 June 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (44) , 75989-76002
Open AccessThe pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes includingTGFB1andMMP13
The pVHL 172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13 The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13
- Open Access
- 1 July 2016
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 129 (13) , 2638-2650
Aggregation dynamics and identification of aggregation-prone mutants of the von Hippel–Lindau tumor suppressor protein
Quality control mechanisms promote aggregation and degradation of misfolded proteins. In budding yeast, the human von Hippel–Lindau protein (pVHL, officially known as VHL) is misfolded and forms aggregates. Here, we investigated the aggregation of three pVHL isoforms (pVHL213, pVHL160, pVHL172) in fission yeast. The full-length pVHL213 isoform aggregates in highly dynamic small puncta and in large spherical inclusions, either close to the nucleus or to the cell ends. The large inclusions contain the yeast Hsp104 chaperone. Aggregate clearance is regulated by proteasomal degradation. The pVHL160 isoform forms dense foci and large irregularly shaped aggregates. In silico, prediction of pVHL aggregation propensity identified a key aggregation-promoting region within exon 2. Consistently, the pVHL172 isoform, which lacks exon 2, formed rare reduced inclusions. We studied the aggregation propensity of pVHL variants harbouring missense mutations found in kidney carcinomas. We show that the P86L mutation stimulated small aggregate formation, the P146A mutation increased large inclusion formation, whereas the I151S mutant destabilized pVHL. The prefoldin subunit Pac10 (the human homolog VBP-1 binds to pVHL) is required for pVHL stability. Reduction of soluble functional pVHL might be crucial in VHL-related diseases.
- 1 July 2016
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 129 (13) , 2638-2650
Open AccessAggregation dynamics and identification of aggregation-prone mutants of the von Hippel–Lindau tumor suppressor protein
Quality control mechanisms promote aggregation and degradation of misfolded proteins. In budding yeast, the human von Hippel–Lindau protein (pVHL, officially known as VHL) is misfolded and forms aggregates. Here, we investigated the aggregation of three pVHL isoforms (pVHL213, pVHL160, pVHL172) in fission yeast. The full-length pVHL213 isoform aggregates in highly dynamic small puncta and in large spherical inclusions, either close to the nucleus or to the cell ends. The large inclusions contain the yeast Hsp104 chaperone. Aggregate clearance is regulated by proteasomal degradation. The pVHL160 isoform forms dense foci and large irregularly shaped aggregates. In silico, prediction of pVHL aggregation propensity identified a key aggregation-promoting region within exon 2. Consistently, the pVHL172 isoform, which lacks exon 2, formed rare reduced inclusions. We studied the aggregation propensity of pVHL variants harbouring missense mutations found in kidney carcinomas. We show that the P86L mutation stimulated small aggregate formation, the P146A mutation increased large inclusion formation, whereas the I151S mutant destabilized pVHL. The prefoldin subunit Pac10 (the human homolog VBP-1 binds to pVHL) is required for pVHL stability. Reduction of soluble functional pVHL might be crucial in VHL-related diseases.
- Open Access
- 27 October 2015
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 5, 241
Unconventional Functions of Mitotic Kinases in Kidney Tumorigenesis
Human tumours exhibit a variety of genetic alterations, including point mutations, translocations, gene amplifications and deletions, as well as aneuploid chromosome numbers. For carcinomas, aneuploidy is associated with poor patient outcome for a large variety of tumour types, including breast, colon and renal cell carcinoma. The Renal cell cancer (RCC) is a heterogeneous carcinoma consisting of different histologic types. The clear renal cell carcinoma (ccRCC) is the most common subtype and represents 85 % of the RCC. Central to the biology of the ccRCC is the loss of function of the Von Hippel Lindau gene but is also associated with genetic instability that could be caused by abrogation of the cell cycle mitotic spindle checkpoint and may involve the Aurora kinases, which regulate centrosome maturation. Aneuploidy can also result from the loss of cell-cell adhesion and apical-basal cell polarity that also may be regulated by the mitotic kinases (Plk1, CK2, DLCK1 and Aurora kinases). In this review, we describe the “non mitotic” unconventional functions of these kinases in renal tumourigenesis.
- 27 October 2015
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 5, 241
Open AccessUnconventional Functions of Mitotic Kinases in Kidney Tumorigenesis
Human tumours exhibit a variety of genetic alterations, including point mutations, translocations, gene amplifications and deletions, as well as aneuploid chromosome numbers. For carcinomas, aneuploidy is associated with poor patient outcome for a large variety of tumour types, including breast, colon and renal cell carcinoma. The Renal cell cancer (RCC) is a heterogeneous carcinoma consisting of different histologic types. The clear renal cell carcinoma (ccRCC) is the most common subtype and represents 85 % of the RCC. Central to the biology of the ccRCC is the loss of function of the Von Hippel Lindau gene but is also associated with genetic instability that could be caused by abrogation of the cell cycle mitotic spindle checkpoint and may involve the Aurora kinases, which regulate centrosome maturation. Aneuploidy can also result from the loss of cell-cell adhesion and apical-basal cell polarity that also may be regulated by the mitotic kinases (Plk1, CK2, DLCK1 and Aurora kinases). In this review, we describe the “non mitotic” unconventional functions of these kinases in renal tumourigenesis.
- Open Access
- 2 June 2015
- Published by Springer Nature in British Journal of Cancer
- Vol. 113 (2) , 336-344
The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform
The von Hippel-Lindau (VHL) gene encodes two mRNA variants. Variant 1 encodes two protein isoforms, pVHL213 and pVHL160, that have been extensively documented in the literature. Variant 2 is produced by alternative splicing of exon 2 and encodes a pVHL isoform of 172 amino acids with a theoretical molecular weight of 19 kDa (pVHL172), the expression of which has never been demonstrated so far due to the absence of suitable antibodies. We have generated an anti-pVHL monoclonal antibody (JD-1956) using pVHL172 recombinant protein. We tested the antibody against exogenous or endogenous expressed proteins in different cell lines. We identified the pVHL172 using a silencing RNA strategy. The epitope of the antibody was mapped using a peptide array. We efficiently detected the three different isoforms of pVHL in cell lines and tumorigenic tissues by western blotting and immunohistochemistry and confirmed for the first time the endogenous expression of pVHL172. The endogenous expression of the three isoforms and particularly the pVHL172 has never been shown before due to a lack of a highly specific antibody since none of the available commercial antibodies distinguish the three isoforms of pVHL in cells or in both normal and cancerous human tissues. Evidence of pVHL172 expression emphasises the need to further study its implication in renal tumorigenesis and VHL disease.
- 2 June 2015
- Published by Springer Nature in British Journal of Cancer
- Vol. 113 (2) , 336-344
Open AccessThe von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform
The von Hippel-Lindau (VHL) gene encodes two mRNA variants. Variant 1 encodes two protein isoforms, pVHL213 and pVHL160, that have been extensively documented in the literature. Variant 2 is produced by alternative splicing of exon 2 and encodes a pVHL isoform of 172 amino acids with a theoretical molecular weight of 19 kDa (pVHL172), the expression of which has never been demonstrated so far due to the absence of suitable antibodies. We have generated an anti-pVHL monoclonal antibody (JD-1956) using pVHL172 recombinant protein. We tested the antibody against exogenous or endogenous expressed proteins in different cell lines. We identified the pVHL172 using a silencing RNA strategy. The epitope of the antibody was mapped using a peptide array. We efficiently detected the three different isoforms of pVHL in cell lines and tumorigenic tissues by western blotting and immunohistochemistry and confirmed for the first time the endogenous expression of pVHL172. The endogenous expression of the three isoforms and particularly the pVHL172 has never been shown before due to a lack of a highly specific antibody since none of the available commercial antibodies distinguish the three isoforms of pVHL in cells or in both normal and cancerous human tissues. Evidence of pVHL172 expression emphasises the need to further study its implication in renal tumorigenesis and VHL disease.